On July 29, 2021 Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, reported that Ofer Haviv, Evogene’s President and CEO, will present at the Jefferies Virtual Industrials Conference, 2021 taking place on August 3-4,2021 (Press release, Evogene, JUL 29, 2021, View Source [SID1234585416]). Mr. Haviv’s presentation will focus on Evogene’s disruptive technologies; its tailor-made engines for product discovery and development and its fields of activity through its main subsidiaries and will take place on Tuesday, August 3, 2021, at 09:00 am, EST.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors attending the conference who wish to meet with Mr. Haviv, may contact Evogene’s Investor Relations team at [email protected] or through the conference’s online meeting platform.